Stockreport

Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering

Eikon Therapeutics, Inc.  (EIKN) 
PDF MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing importa [Read more]